Regenxbio: Q2 Earnings Snapshot

August 3, 2022 GMT

ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Wednesday reported a loss of $68.2 million in its second quarter.

The Rockville, Maryland-based company said it had a loss of $1.58 per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.44 per share.

The biotechnology company posted revenue of $32.6 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $26 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on RGNX at